Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 114, Issue 5, Pages 1135-1144
Publisher
Wiley
Online
2012-11-29
DOI
10.1002/jcb.24456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
- (2012) J M Houthuijzen et al. BRITISH JOURNAL OF CANCER
- Mesenchymal stem cells engineered for cancer therapy
- (2011) Khalid Shah ADVANCED DRUG DELIVERY REVIEWS
- Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer
- (2011) M. Gallo et al. ANNALS OF ONCOLOGY
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
- (2011) Jeanine M.L. Roodhart et al. CANCER CELL
- The IL-8-Regulated Chemokine Receptor CXCR7 Stimulates EGFR Signaling to Promote Prostate Cancer Growth
- (2011) R. K. Singh et al. CANCER RESEARCH
- Steps in prostate cancer progression that lead to bone metastasis
- (2011) Jung-Kang Jin et al. INTERNATIONAL JOURNAL OF CANCER
- Bone-metastatic prostate carcinoma favors mesenchymal stem cell differentiation toward osteoblasts and reduces their osteoclastogenic potential
- (2011) V. Fritz et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- Bone metastasis: mechanisms and therapeutic opportunities
- (2011) Larry J. Suva et al. Nature Reviews Endocrinology
- Pathogenesis of osteoblastic bone metastases from prostate cancer
- (2010) Toni Ibrahim et al. CANCER
- Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
- (2010) Scott A. Bergfeld et al. CANCER AND METASTASIS REVIEWS
- Epidermal growth factor receptor plays an anabolic role in bone metabolism in vivo
- (2010) Xianrong Zhang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Blood-derived human osteoclast resorption activity is impaired by Hyaluronan-CD44 engagement via a p38-dependent mechanism
- (2010) Eliana Pivetta et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells
- (2010) Antonella De Luca et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Therapeutic targeting of the prostate cancer microenvironment
- (2010) Maria Karlou et al. Nature Reviews Urology
- Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth
- (2010) Veronica R. Placencio et al. PLoS One
- Examining the Metastatic Niche: Targeting the Microenvironment
- (2010) Theresa Guise SEMINARS IN ONCOLOGY
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
- (2009) Frédéric R Santer et al. ENDOCRINE-RELATED CANCER
- The epidermal growth factor system of ligands and receptors in cancer
- (2009) William J. Gullick EUROPEAN JOURNAL OF CANCER
- Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis
- (2009) Nastaran Z. Kuhn et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1
- (2009) Marco Colombatti et al. PLoS One
- EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling
- (2009) Alyse M. DeHaan et al. PROSTATE
- Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells
- (2008) A. Angelucci et al. ENDOCRINE-RELATED CANCER
- Chemotherapeutic drugs and human tumor cells cytokine network
- (2008) Vera Levina et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
- (2007) Donatella Aldinucci et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation